Guenther, Andreas <br/><br/>
The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation.  [electronic resource] 

 -  International journal of cancer  Jan 2010 
 - 239-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.24758  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Bone Density Conservation Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Diphosphonates--pharmacology<br/>Disease Models, Animal<br/>Female<br/>Humans<br/>Imidazoles--pharmacology<br/>Mice<br/>Mice, SCID<br/>Multiple Myeloma--drug therapy<br/>Protein Prenylation<br/>Transplantation, Heterologous<br/>Zoledronic Acid